Sign in to continue:

Tuesday, March 10th, 2026

Henan Jinyuan Hydrogenated Chemicals Announces Board Meeting to Approve 2025 Annual Results and Dividend on March 23, 2026 1

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Announces Upcoming Board Meeting for 2025 Annual Results and Dividend Consideration

Henan Jinyuan Hydrogenated Chemicals Schedules Board Meeting to Approve 2025 Annual Results and Final Dividend

Key Highlights

  • Board Meeting Date: The board of directors of Henan Jinyuan Hydrogenated Chemicals Co., Ltd. will convene on Monday, 23 March 2026.
  • Purpose of Meeting:
    • To review and potentially approve the audited annual results for the year ended 31 December 2025.
    • To consider and approve, if appropriate, the payment of a final dividend for shareholders.
    • To manage other business matters as may arise during the meeting.
  • Announcement of Results: The company will publish the audited annual results on both the websites of The Stock Exchange of Hong Kong Limited and the company itself.

Details for Shareholders and Investors

  • Potential Price-Sensitive Information:
    • The approval and announcement of the audited annual results is a critical event, as it will provide insights into the company’s financial performance for 2025. Strong or weak results can significantly impact the company’s share price.
    • The consideration and potential approval of a final dividend is particularly important for income-focused investors. Any announcement regarding dividend payments, whether positive or negative, could directly influence the company’s market valuation and share price.
  • Corporate Governance:
    • The current board composition is as follows:
      • Executive Directors: Mr. Wang Zengguang and Mr. Qiao Erwei
      • Non-executive Directors: Mr. Yiu Chiu Fai, Mr. Xu Fenglei, and Mr. Wang Lijie
      • Independent Non-executive Directors: Ms. Wong Yan Ki Angel, Mr. Di Zhigang, and Ms. Leung Sin Yeng Winnie

What Should Investors Watch For?

  • Annual Results: Investors should closely monitor the release of the audited annual results, as any significant deviation from market expectations could cause share price volatility.
  • Dividend Announcement: The board’s decision on whether to pay a final dividend will be a key indicator of the company’s financial health and management’s outlook on future cash flows.
  • Timelines: The market may react in anticipation of the 23 March 2026 board meeting, and further price action is likely once the official results and dividend decisions are published.

Conclusion

The forthcoming board meeting of Henan Jinyuan Hydrogenated Chemicals Co., Ltd. represents a potentially price-sensitive event for investors. The consideration of the 2025 audited annual results and the possible declaration of a final dividend are both key factors that could influence the company’s share price in the short-term. Investors are advised to stay alert for the official announcements following the meeting.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with their financial advisors before making any investment decisions. The author and publisher accept no liability for any losses incurred as a result of the information provided herein.


View JINYUAN HCHEM Historical chart here



Disclosure of Morgan Stanley Dealings in ENN Natural Gas Co., Ltd. Shares – Privatisation Scheme Update (March 2026)

Disclosure of Dealings in ENN Natural Gas Co., Ltd. Shares – Potential Impact for Investors Disclosure of Dealings in ENN Natural Gas Co., Ltd. Shares – Key Developments for Investors Summary of Key Points...

Public Disclosure of Morgan Stanley Dealings in Bright Smart Securities & Commodities Group Limited Shares – February 2026

Potential Price-Sensitive Implications for Shareholders The disclosed dealings are related to a possible mandatory general offer for Bright Smart Securities & Commodities Group Limited, which could significantly impact the company’s share price depending on...

CF PharmTech, Inc. Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Eligible Securities List Effective March 2026

CF PharmTech, Inc. Included in Shanghai and Shenzhen-Hong Kong Stock Connect – What Investors Need to Know CF PharmTech, Inc. Achieves Major Milestone: Inclusion in Shanghai and Shenzhen-Hong Kong Stock Connect Key Highlights from...

   Ad